Physician profile
Abdollah Assad
NPI 1588633143
$3,991.00
in general payments reported to CMS, 2019-2025
18 companies · $60.28 in 2025
The $60.28 reported for 2025 was less than what a typical Geriatric Psychiatry provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $618 · 2021: $1,371 · 2022: $439 · 2023: $312 · 2024: $314 · 2025: $60.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $921.59 | 2020-2024 | Caplyta |
| Abbvie INC. | $608.13 | 2021-2024 | Vraylar |
| Takeda Pharmaceuticals U.S.A., INC. | $413.51 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $382.79 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $349.55 | 2019-2022 | |
| Allergan, INC. | $331.91 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $227.57 | 2019-2021 | |
| Corium, LLC | $140.93 | 2022-2024 | Azstarys |
| Alkermes, INC. | $119.05 | 2021-2024 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $117.77 | 2019 | |
| Eisai INC. | $93.34 | 2020-2021 | |
| Lundbeck LLC | $66.75 | 2019 | |
| Almatica Pharma LLC | $61.28 | 2021-2025 | Loreev Xr |
| Adlon Therapeutics L.P. | $55.43 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $34.83 | 2025 | Cobenfy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $31.94 | 2019 | |
| Arbor Pharmaceuticals, INC. | $22.93 | 2020 | |
| Sunovion Pharmaceuticals INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdollah Assad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.